安進公司
(AMGN)

  • 股價
    273.83
  • 漲跌
    -3.63
  • 漲幅
    -1.31%
  • 成交量
    34.4萬
減重更持久,一月僅需打一針,還能治療脂肪肝……近期,Viking、安進、勃林格殷格翰等多家藥企披露了旗下GLP-1藥物在積極研究數據,也將壓力給到了諾和諾德、禮來兩大GLP-1巨頭。 多家藥企公布GLP-1減肥藥積極數據 當地時間2月27日,美...
    YahooFinanceBusiness
    On Tuesday, Viking Therapeutics (NASDAQ: VKTX), a clinical-stage biotech specializing in treatments for metabolic diseases, saw its stock price surge by a staggering 121% in response to a clinical update for its mid-stage obesity candidate, VK2735. Over the past three years, this company's shares h
      YahooFinanceBusiness
      Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2023 Earnings Call Transcript February 27, 2024
      Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.03, expectations were $0.58. LGND isn't one of the 30 most popular stocks among hedge funds at the end of the thi
        YahooFinanceBusiness
        Feb. 26 marked the second major shakeup in the Dow Jones Industrial Average in the last five years. The other was when Salesforce, Honeywell International, and Amgen replaced ExxonMobil, RTX, and Pfizer (respectively) in 2020.
        Amazon (NASDAQ: AMZN) just replaced Walgreens Boots Alliance, which inc
          YahooFinanceBusiness
          Viking Therapeutics stock soared as much as 104% on Tuesday after a successful drug trial.
          Viking's GLP-1 weight loss drug led to a significant reduction in body weight among patients.
          The drug could ultimately compete with weight loss drugs from Eli Lilly and Novo Nordisk if its Phase 3 trials p
            聯準會官員持續釋出鴿派訊號,市場消化新一波零售商財報和經濟數據,美股主指週二 (27 日) 漲跌互見,蘋果傳出放棄電動車項目,並將專注於 AI 研發,推動其股價翻紅超過 0.8%。